Saarinen EK, Kuusimäki T, Lindholm K, Niemi K, Honkanen EA, Noponen T, Seppänen M, Ihalainen T, Murtomäki K, Mertsalmi T, Jaakkola E, Myller E, Eklund M, Nuuttila S, Levo R, Chaudhuri KR, Antonini A, Vahlberg T, Lehtonen M, Joutsa J, Scheperjans F, Kaasinen V. Dietary Caffeine and Brain Dopaminergic Function in Parkinson Disease. Ann Neurol 2024 Aug;96(2):262-275.
Ellis EG, Meyer GM, Kaasinen V, Corp DT, Pavese N, Reich MM, Reich MM. Multimodal neuroimaging to characterize symptom-specific networks in movement disorders. NPJ Parkinsons Dis 2024 Aug 14;10(1):154.
Schaper FLWVJ, Morton-Dutton M, Pacheco-Barrios N, Turner JI, Drew W, Khosravani S, Joutsa J, Fox MD. Brain lesions causing parkinsonism versus seizures map to opposite brain networks. Brain Commun 2024 Jun 5;6(3):fcae196.
Theys C, Jaakkola E, Melzer TR, De Nil LF, Guenther FH, Cohen AL, Fox MD, Joutsa J. Localization of stuttering based on causal brain lesions. Brain 2024 Jun 3;147(6):2203-2213.
Bellmunt-Gil A, Vorobyev V, Parkkola R, Lötjönen J, Joutsa J, Kaasinen V. Frontal white and gray matter abnormality in gambling disorder: A multimodal MRI study. J Behav Addict 2024 Jun 26;13(2):576-586.
Niemi KJ, Huovinen A, Jaakkola E, Glerean E, Nummenmaa L & Joutsa J. Bodily maps of symptoms and emotions in Parkinson’s disease. Mov Disord 2024 Apr 8.
Sihvonen AJ, Ferguson MA, Chen V, Soinila S, Särkämö T, Joutsa J. Focal brain lesions causing acquired amusia map to a common brain network. J Neurosci 2024 Feb 29:e1922232024
Brück A, Pullinen J, Nummelin J, Lehto S, Joutsa J. No efficacy with noninvasive brain stimulation for painful legs and moving toes: a case report. Case Rep Neurol 2024 Feb 28;16(1):85-88.
Rodriguez-Porcel F, Sarva H, Joutsa J, Falup-Pecurariu C, Shukla AW, Mehanna R, Smilowska K, Lanza G, Filipovic SR, Shalash A, Ferris M, Jankovic J, Espay AJ, Pandey S & MDS PSMD study group. Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society members. J Neurol Sci 2024 Mar 15;458:122925.
Soleimani G, Joutsa J, Moussawi K, Siddiqi SH, Kuplicki R, Bikson M, Paulus MP, Fox MD, Hanlon CA, Ekhtiari H. Converging Evidence for Frontopolar Cortex as a Target for Neuromodulation in Addiction Treatment. Am J Psychiatry 2024 Feb 1;181(2):100-114
Honkanen EA, Rönkä J, Pekkonen E, Aaltonen J, Koivu M, Eskola O, Eldebakey H, Volkmann J, Kaasinen V, Reich MM, Joutsa J. GPi-DBS-induced brain metabolic activation in cervical dystonia. J Neurol Neurosurg Psychiatry 2024 Mar 13;95(4):300-308.
Rodriguez-Porcel F, Sarva H, Joutsa J, Falup-Pecurariu C, Shukla AW, Mehanna R, Śmiłowska K, Lanza G, Filipović SR, Shalash A, Ferris M, Jankovic J, Espay AJ, Pandey S. Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society members. J Neurol Ski 2024 Mar 15:458:122925.
2023
Joutsa J, Lipsman N, Horn A, Cosgrove GR, Fox MD. The return of the lesion for localization and therapy. Brain. 2023 Aug 1;146(8):3146-3155.
Räty V, Eklund M, Nuuttila S, Jaakkola E, Mäkinen E, Murtomäki K, Nojonen T, Levo R, Mertsalmi T, Joutsa J, Scheperjans F, Kaasinen V. Floating door sign does not differentiate Parkinson’s disease from essential tremor. Clin Park Relat Disord. 2023 Jan 27;8:100184.
Younger E, Ellis EG, Parsons N, Pantano P, Tommasin S, Caeyenberghs K, Benito-Leon J, Romero JP, Joutsa J, Corp DT. Mapping essential tremor to a common brain network using functional connectivity analysis. Neurology. 2023 Aug 18;10.1212
Belmunt-Gil A, Majuri J, Arponen E, Kaasinen V, Joutsa J. Abnormal frontostriatal connectivity and serotonin function in gambling disorder: A preliminary exploratory study. J Behav Addict. 2023 Aug 9.
Corp DT, Morrison-Ham J, Jinnah HA, Joutsa J. The functional anatomy of dystonia: recent developments. Int Rev Neurobiol. 2023;169:105-36.
Schaper FLWVJ, Nordberg J, Cohen AL, Lin C, Hsu J, Horn A, Ferguson MA, Siddiqi SH, Soussand L, Winkler A, Simo M, Bruna J, Rheims S, Guenot M, Bucci M, Nummenmaa L, Staals J, Colon A, Ackermans L, Bubrick E, Peters J, Wu O, Rost N, Grafman J, Blumenfeld H, Temel Y, Rouhl R, Joutsa J, Fox MD. Mapping lesion-related epilepsy to a human brain network. JAMA Neurol. 2023 Sep 1;80(9):891-902.
Ellis EG, Joutsa J, Morrison-Ham J, Younger E, Saward J, Caeyenberghs K, Corp DT. Large scale ALE meta-analysis of parkinsonian disorders. Brain commun 2023;5(3)fcad172
Murtomäki K, Joutsa J, Mertsalmi T, Jaakkola E, Mäkinen E, Levo R, Eklund M, Nuuttila S, Pekkonen E, Noponen T, Ihalainen T, Kaasinen V, Scheperjans F. Dopamine transporter binding in the brain is linked to irritable bowel syndrome in early Parkinson’s disease. Brain Behav e3097
Joutsa J, Lipsman N, Horn A, Cosgrove GR, Fox MD. The return of the lesion for localization and therapy. Brain 2023
Norberg J, Schaper FLWVJ, Bucci M, Nummenmaa L, Joutsa J. Brain lesion locations associated with secondary seizure generalization in tumors and strokes. Hum Brain Mapp 2023
Zouki JJ, Ellis EG, Morrison-Ham J, Thomson P, Jesuthasan A, Al-Fatly B, Joutsa J, Silk TJ, Corp DT. Mapping a network for tics in Tourette syndrome using causal lesions and structural alterations. Brain commun 2023;5(3)fcad105
Räty V, Eklund M, Nuuttila S, Jaakkola E, Mäkinen E, Murtomäki K, Nojonen T, Levo R, Mertsalmi T, Joutsa J, Scheperjans F, Kaasinen V. Floating door sign does not differentiate Parkinson’s disease from essential tremor. Clin Parkinsonism Relat Disord. 2023;8:100184.
Kaasinen V, Honkanen EA, Lindholm K, Jaakkola EA, Majuri J, Parkkola R, Noponen T, Vahlberg T, Voon V, Clark L, Joutsa J, Seppänen M. Serotonergic and dopaminergic control of impulsivity in gambling disorder. Addiction Biol 2023;28(2) e13264
Waggan I, Rissanen E, Tuisku J, Joutsa J, Helin S, Parkkola R, Rinne JO, Airas L. Adenosine A 2A receptor availability in patients with early- and moderate-stage Parkinson's disease. J Neurol. 2023;270(1):300-10.
2022
Morrison-Ham J, Clark GM, Ellis EG, Cerins A, Joutsa J, Enticott PG, Corp DT. Effects of non-invasive brain stimulation in dystonia: a systematic review and meta-analysis. Ther Adv Neurol Disord, 2022;15:17562864221138144
Huovinen A, Jaakkola EA, Joutsa J. Impulse control disorder behaviors in dystonia. Mov Disord 2022;37(12):2460-1.
Kim NY, Taylor JJ, Kim YW, Borsook D, Joutsa J, Li J, Quesada C, Peyron R, Fox MD. Network effects of brain lesions causing central post-stroke pain. Ann Neurol. 2022;92(5):834-45.
Pandey S, Joutsa J, Mehanna R, Wagle Shukla A, Rodriguez-Porcel R, Espay AJ. Gaps, controversies, and proposed roadmap for research in poststroke movement disorders. Mov Disord. 2022;37(10):1996-2007.
Corp DT, Greenwood C, Morrison-Ham J, Pullinen J, McDowall G, Younger E, Jinnah H, Fox MD, Joutsa J. Clinical and structural findings in patients with lesion-induced dystonia: Descriptive and quantitative analysis of published cases. Neurology 2022;99(18):e1957-67.
Kokkonen A, Honkanen EA, Corp DT, Joutsa J. Neurobiological effects of deep brain stimulation: A systematic review of molecular brain imaging studies. Neuroimage 2022;260:119473.
Joutsa J, Corp DT, Fox MD. Lesion network mapping for symptom localization: recent developments and future directions. Curr Opin Neurol. 2022;35(4):453-459.
Joutsa J, Moussawi K, Siddiqi SH, Abdolahi A, Drew W, Cohen AL, Ross TJ, Deshpande HU, Wang HZ, Bruss J, Stein EA, Volkow ND, Grafman JH, Winjngaarden EV, Boes AD, Fox MD. Brain lesions disrupting addiction map to a common human brain circuit. Nat Med. 2022;28(6):1249-1255.
Eklund M, Nuutila S, Joutsa J, Jaakkola E, Mäkinen E, Honkanen EA, Lindholm K, Vahlberg T, Noponen T, Ihalainen T, Murtomäki K, Nojonen T, Levo R, Mertsalmi T, Scheperjans F, Kaasinen V. Diagnostic value of micrographia in Parkinson’s disease: a study with [123 I]FP-CIT SPECT. J Neural Transm (Vienna) 2022;129(7):895-904.
Murtomäki K, Mertsalmi T, Jaakkola E, Mäkinen E, Levo R, Nojonen T, Eklund M, Nuuttila S, Lindholm K, Pekkonen E, Joutsa J, Noponen T, Ihalainen T, Kaasinen V, Scheperjans F. Gastrointestinal symptoms and dopamine transporter asymmetry in early Parkinson’s disease. Mov Disord. 2022;37(6):1284-1289.
Reich MM, Hsu J, Ferguson M, Schaper FLWVJ, Joutsa J, Roothans J, Nickl RC, Frankemolle-Gilbert A, Alberts J, Volkmann J, Fox MD. A brain network for deep brain stimulation induced cognitive decline in Parkinson’s disease. Brain 2022;145(4):1410-1421.
Sillanpää M, Hermann B, Rinne JO, Parkkola R, Saarinen MM, Karrasch M, Saunavaara J, Rissanen E, Joutsa J, Shinnar S. Differences in brain changes between adults with childhood-onset epilepsy and controls: A prospective population-based study. Acta Neurol Scand. 2022;145(3):322-331.
2021
Manninen S, Karjalainen T, Tuominen LJ, Hietala J, Kaasinen V, Joutsa J, Rinne JO, Nummenmaa L. Cerebral grey matter density is associated with neuroreceptor and neurotransporter availability: A combined PET and MRI study. Neuroimage 2021;235:117968
Nuuttila S, Eklund M, Joutsa J, Jaakkola E, Mäkinen E, Honkanen EA, Lindholm K, Noponen T, Ihalainen T, Murtomäki K, Nojonen T, Levo R, Mertsalmi T, Scheperjans F, Kaasinen V. Diagnostic accuracy of glabellar tap sign for Parkinson’s disease. J Neural Transm (Vienna) 2021;128(11):1655-1661.
Honkanen EA, Noponen T, Hirvilammi R, Lindholm K, Parkkola R, Joutsa J, Varrone A, Kaasinen V. Sex correction improves the accuracy of clinical dopamine transporter imaging. EJNMMI Res. 2021;11(1):82.
Skandali N, Majuri J, Joutsa J, Arponen E, Forsback S, Kaasinen V, Voon V. The neural substrates of risky rewards and losses in healthy volunteers and patient groups: a PET imaging study. Psychol Med. 2021;1-9.
Joutsa J, Darby RR, Fox MD. Lesion network mapping using functional resting state fMRI. Book Chapter in Lesion to Symptom Mapping: Principles and Tools
Kaasinen V, Scheperjans F, Kärppä M, Korpela J, Brück A, Sipilä JOT, Joutsa J, Järvelä J, Eerola-Rautio J, Martikainen MH, Airaksinen K, Stebbins GT, Martinez-Martin P, Goetz CG, Lin J, Luo S, Pekkonen E. Validation of the finnish version of the unified dyskinesia rating scale. Eur Neurol. 2021;84(6):444-449.
Jaakkola E, Joutsa J. Screening instrument and prevalence of impulse control disorders. Mov Disord Clin Pract. 2021;8(5):816-817.
Honkanen EA, Korpela J, Pekkonen E, Kaasinen V, Reich MM, Joutsa J. Reappearance of symptoms after discontinuing GPi-DBS in cervical dystonia. Mov Disord Clin Pract. 2021;8(3):306-11.
Jaakkola E, Huovinen A, Kaasinen V, Joutsa J. No change in prevalence of impulse control disorder behaviors in Parkinson’s disease during the last decade. Mov Disord. 2021;36(2):521-3.
Corp DT, He J, Cooke D, Perellon-Alfonso R, Joutsa J, Pascual-Leone A, Fox MD, Hyde C. Expedited interhemispheric inhibition; a simple method to collect additional IHI data in the same amount of time. Brain Topography 2021;34(1):1-5.
Kim NY, Hsu J, Talmasov D, Joutsa J, Soussand L, Wu O, Rost NA, Morenas-Rodriguez E, Martí-Fàbregas J, Pascual-Leone A, Corlett PR, Fox MD. Lesions causing hallucinations localize to one common brain network. Molecular Psychiatry 2021;26(4):1299-1309.
2020
Corp DT, Bereznicki HGK, Clark GM, Youssef GJ, Fried PJ, Jannati A, Davies CB, Gomes-Osman J, Stamm J, Chung SW, Bowe SJ, Rogash NC, Fitzgerald PB, Koch G, Di Lazzaro V, Pascual-Leone A, Enticott PG, Big TMS Data Collaboration. Large-scale analysis of interindividual variability in theta-burst stimulation data: results from the ‘Big TMS Data Collaboration’. Brain Stimul. 2020;13(5):1476-88. (Study group publication)
Tremblay S, Tuominen L, Zayed V, Pascual-Leone A, Joutsa J. The study of noninvasive brain stimulation using molecular brain imaging: A systematic review. NeuroImage 2020;219:117023
Honkanen E, Korpela J, Kaakkola S, Joutsa J. Dystonian patofysiologia ja hoito [Patophysiology and treatment of dystonia]. Duodecim 2020;135(16):1805-11.
Kokkonen A, Kaasinen V, Jutila L, Tuominen L, Rinne JO, Joutsa J. PET aivosairauksissa [PET imaging in brain disorders]. Duodecim 2020;136(9):1110-7.
Jaakkola E, Kaasinen V, Joutsa J. Parkinsonin taudin ei-motoriset oireet [Non-motor symptoms in Parkinson’s disease]. Duodecim 2020; 136(4):367-73.
Nummenmaa L, Karjalainen T, Isojärvi J, Kantonen T, Tuisku J, Kaasinen V, Joutsa J, Nuutila P, Kalliokoski K, Hirvonen J, Hietala J, Rinne JO. Lowered endogeneous mu-opioid receptor availability in subclinical depression and anxiety. Neuropsychopharmacology 2020;45(11):1953-9.
Li S, Eshghi M, Khan S, Tian Q, Joutsa J, Ou Y, Wang Q, Kong J, Rosen BR, Ahveninen J, Nummenmaa A. Localizing central swallowing functions by combining non-invasive brain stimulation with neuroimaging. Brain Stimulation 2020;13(5):1207-10.
Voon V, Joutsa J, Majuri J, Forsback S, Arponen E, Kaasinen V. The neurochemical substrates of habitual and goal-directed control. Transl Psychiatry 2020;10(1):84
Burke MJ, Joutsa J, Cohen AL, Soussand L, Cooke D, Burstein R, Fox MD. Mapping migraine to a common brain network. Brain 2020;143(2):541-53.
2019
Makarov S, Bogdanov G, Noetscher G, Appleyard W, Ludwig R, Joutsa J, Deng ZD. Design and analysis of a whole-body noncontact electromagnetic subthreshold stimulation device with field modulation targeting nonspecific neuropathic pain. Brain and human body modelling. 2019, Chapter 5, 85-123.
Honkanen EA, Saari L, Orte K, Gardberg M, Noponen T, Joutsa J, Kaasinen V. Reply to: The time delay between in vivo imaging and postmortem data poses a caveat on "no link" findings. Mov Disord. 2019;34(10):1580-1581.
Makarov S, Bogdanov G, Noetscher G, Appleyard W, Ludwig R, Joutsa J, Deng ZD. Design and Analysis of a Whole-Body Noncontact Electromagnetic Subthreshold Stimulation Device with Field Modulation Targeting Nonspecific Neuropathic Pain. In: Makarov S, Horner M, Noetscher G, editors. Brain and Human Body Modeling: Computational Human Modeling at EMBC 2018 [Internet]. Cham (CH): Springer; 2019. Chapter 5.
Kim NY, Hsu J, Talmasov D, Joutsa J, Soussand L, Wu O, Rost NS, Morenas-Rodríguez E, Martí-Fàbregas J, Pascual-Leone A, Corlett PR, Fox MD. Lesions causing hallucinations localize to one common brain network. Mol Psychiatry. 2019 Oct 28.
Joutsa J, Shih LC, Fox MD. Mapping holmes tremor circuit using the human brain connectome. Ann Neurol. 2019;86(6):812-820.
Padmanabhan JL, Cooke D, Joutsa J, Siddiqi SH, Ferguson M, Darby RR, Soussand L, Horn A, Kim NY, Voss JL, Naidech AM, Brodtmann A, Egorova N, Gozzi S, Phan TG, Corbetta M, Grafman J, Fox MD. A Human Depression Circuit Derived From Focal Brain Lesions. Biol Psychiatry. 2019;86(10):749-758.
Kaasinen V, Joutsa J, Rissanen E, Airas L, Soilu-Hänninen M, Noponen T. Progressive dopaminergic defect in a patient with primary progressive multiple sclerosis. Mult Scler Relat Disord. 2019;36:101385.
Li Y, Wang Z, Boileau I, Dreher JC, Gelskov S, Genauck A, Joutsa J, Kaasinen V, Perales JC, Romanczuk-Seiferth N, Ruiz de Lara CM, Siebner HR, van Holst RJ, van Timmeren T, Sescousse G. Altered orbitofrontal sulcogyral patterns in gambling disorder: a multicenter study. Transl Psychiatry. 2019;9(1):186.
Majuri J, Joutsa J. Molecular imaging of impulse control disorders in Parkinson’s disease. Eur J Nucl Med Mol Imaging. 2019;46(11)2220-2222.
Honkanen EA, Kemppainen N, Noponen T, Seppänen M, Joutsa J, Kaasinen V. Bupropion causes misdiagnosis in brain dopamine transporter imaging for parkinsonism. Clin Neuropharmacol. 2019;42(5):181-183.
Honkanen EA, Saari L, Orte K, Gardberg M, Noponen T, Joutsa J, Kaasinen V. No link between striatal dopaminergic axons and dopamine transporter imaging in Parkinson’s disease. Mov Disord. 2019;34(10):1562-1566.
Kaasinen V, Kankare T, Joutsa J, Vahlberg T. Presynaptic striatal dopaminergic function in atypical parkinsonisms: A metaanalysis of imaging studies. J Nucl Med. 2019;60(12):1757-1763.
Kübler D, Scroll H, Hamker FH, Joutsa J, Buchert R, Kühn AA. The effect of dopamine on response inhibition in Parkinson's disease relates to age-dependent patterns of nigrostriatal degeneration. Parkinsonism Relat Disord. 2019;63:185-190.
Jaakkola E, Joutsa J, Mäkinen E, Noponen T, Pitkonen M, Levo R, Mertsalmi T, Scheperjans F, Kaasinen V. Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [123I]FP-CIT SPECT. J Neurol Sci 2019;404:124-7.
Li Y, Wang Z, Boileau I, Dreher JC, Gelskov S, Genauck A, Joutsa J, Kaasinen V, Perales J, Romanczuk-Seiferth N, Ruiz de Lara CM, Siebner HR, van Hols RJ, van Timmeren T, Sescousse G. Altered orbitofrontal sulcogyral patterns in gambling disorder: a multicenter study. Transl Psychiatry 2019;9(1):186.
Corp DT#,Joutsa J#, Darby RR, Delnooz CCS, van den Warrenburg BPC, Ren J, Batla A, Bhatia KP, Jinnah HA, Liu H, Fox MD. Network localization of cervical dystonia based on causal brain lesions. (#Equal contribution) Brain 2019;142(6):1660-74.
Mäkinen E, Joutsa J, Jaakkola E, Johansson J, Noponen T, Levo R, Pitkonen M, Mertsalmi T, Scheperjans F, Kaasinen V. Individual parkinsonian motor signs and striatal dopamine transporter deficiency: A study with [I-123]FP-CIT SPECT. J Neurol 2019;266(4):826-34.
Darby RR, Joutsa J, Fox MD. Network localization of heterogeneous neuroimaging findings. Brain 2019;142(1):70-9.
2018
Railo H, Olkoniemi H, Eeronheimo E, Pääkkönen O, Joutsa J, Kaasinen V. Dopamine and eye movement control in Parkinson’s disease: deficits in corollary discharge signals. PeerJ 2018;e6038
Joutsa J, Horn A, Hsu J, Fox MD. Localization of parkinsonism based on focal brain lesions. Brain 2018;141(8):2445-56. *Editor’s choice, August 2018*
Darby RR,Joutsa J, Burke MJ, Fox MD. Lesion network localization of free will. Proc Natl Acad Sci U S A 2018;115(42):10792-7.
Joutsa J#, Shih LC#, Horn A, Reich MM, Wu O, Rost N, Fox MD. Identifying therapeutic targets from spontaneous beneficial brain lesions. (#Equal contribution)Ann Neurol. 2018;84(1):153-7.
Majuri J,Joutsa J, Arponen E, Forsback S, Kaasinen V. Dopamine synthesis capacity correlates with mu-opioid receptor availability in the human basal ganglia: a triple-tracer PET study. NeuroImage 2018;183:1-6
Hämäläinen S, Joutsa J, Sihvonen AJ, Leminen A, Lehtonen M. Beyond volume: A surface-based approach to bilingualism-induced grey matter changes. Neuropsychologia 2018;117:1-7
Joutsa J, Karlsson HK, Majuri J, Nuutila P, Helin S, Kaasinen V, Nummenmaa, L. Binge eating disorder and morbid obesity are associated with lowered mu-opioid receptor availability in the brain. Psychiatry Res Neuroimaging. 2018;276:41-5
Sahlsten H, Taiminen T, Karukivi M, Sjösten N, Nikkilä J, Virtanen J, Paavola J, Joutsa J, Niinivirta-Joutsa K, Takala M, Holm A, Rauhala E, Löyttyniemi E, Johansson R, Jääskeläinen SK. Psychiatric (axis I) and personality (axis II) disorders and subjective psychiatric symptoms in chronic tinnitus. Int J Audiol. 2018;57(4):302-12
Lukasik K, Lehtonen MH, Salmi J, Meinzer M, Joutsa J, Laine MJ. No effects of stimulating the left ventrolateral prefrontal cortex with tDCS on verbal working memory updating. Front Neurosci. 2018;11:738.
Kemppainen NM, Johansson J, Teuho J, Parkkola R, Joutsa J, Ngandu T, Solomon A, Stephen R, Hänninen T, Paajanen T, Laatikainen T, Soininen H, Jula A, Rokka J, Rissanen E, Vahlberg T, Peltoniemi J, Kivipelto M, Rinne JO. Brain Amyloid Load and Its Associations with Cognition and Vascular Risk Factors in FINGER Study. Neurology. 2018;90(3):e206-13.
2017
Majuri J,Joutsa J, Johansson J, Voon V, Parkkola R, Alho H, Arponen E, Kaasinen V. Serotonin transporter density in binge eating disorder and pathological gambling: A PET study with [11C]MADAM. Eur Neuropsychopharmacology. 2017;27(12):1281-8.
Joutsa J, Rinne JO, Karrasch M, Hermann B, Johansson J, Anttinen A, Eskola O, Helin S, Shinnar S, Sillanpää M. Brain glucose metabolism and its relation with amyloid load in middle-aged adults with childhood-onset epilepsy. Epilepsy Res. 2017:137:69-72.
Saarela C, Joutsa J, Laine M, Parkkola R, Rinne J, Karrasch M. Regional gray matter correlates of memory emotion-laden words in middle-aged and older adults: A Voxel-based morphometry study. PlosOne 2017;12(8):e0182541.
Jaakkola E, Joutsa J, Mäkinen E, Johansson J, Kaasinen V. Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson’s disease. Eur J Neurol. 2017;24(11):1341-7.
Mäkinen E, Joutsa J, Vahlberg T, Kaasinen V. Survival in Parkinson’s disease in relation to striatal dopamine transporter binding. Parkinsonism Relat Disord. 2017;42:66-72.
Sahlsten H, Virtanen J, Joutsa J, Niinivirta-Joutsa K, Löyttyniemi E, Johansson R, Paavola J, Taiminen T, Sjösten N, Salonen J, Holm A, Rauhala E, Jääskeläinen SK. Electric field-navigated transcranial magnetic stimulation for chronic tinnitus: a randomized, placebo-controlled study. Int J Audiol. 2017;56(9):692-700.
Garcia-Ramos C, Bobholz S, Dabbs K, Hermann B, Joutsa J, Rinne JO, Karrasch M, Prabhakaran V, Shinnar S, Sillanpää M. Brain structure and organization five decades after childhood onset epilepsy. Human Brain Mapping 2017;38(6):3289-99.
Joutsa J, Rinne JO, Hermann B, Karrasch M, Anttinen A, Shinnar S, Sillanpää M. Association between childhood-onset epilepsy and amyloid burden 5 decades later. JAMA Neurology 2017;74(5):583-90.
Saari L, Kivinen K, Gardberg M, Joutsa J, Noponen T, Kaasinen V. Dopamine transporter imaging does not predict the number of nigral neurons in Parkinson disease. Neurology. 2017;88(15):1461-7.
Karrasch M, Tiitta P, Hermann B, Joutsa J, Shinnar S, Rinne J, Anttinen A, Sillanpää M. Cognitive Outcome in Childhood-Onset Epilepsy: A Five-Decade Prospective Cohort Study. J Int Neuropsychol Soc. 2017;23(4):332-40.
Majuri J,Joutsa J, Johansson J, Voon V, Alakurtti K, Parkkola R, Lahti T, Alho H, Hirvonen J, Arponen E, Forsback S, Kaasinen V. Dopamine and Opioid Neurotransmission in Behavioral Addictions: A Comparative PET Study in Pathological Gambling and Binge Eating. Neuropsychopharmacology. 2017;42(5):1169-77.
2016
Tosukhowong P, Boonla C, Dissayabutra T, Kaewwilai L, Muensri S, Chotipanich C, Joutsa J, Rinne J, Bhidayasiri R. Biochemical and clinical effects of whey protein supplementation in Parkinson’s disease: A pilot study. J Neurol Sci. 2016;367:162-70.
Mäkinen E, Joutsa J, Johansson J, Mäki M, Seppänen M, Kaasinen V. Visual versus automated analysis of [I-123]FP-CIT SPECT scans in parkinsonism. J Neural Transm. 2016;123(11):1309-18.
Joutsa J, Erälinna JP, Jokela M. Painless legs and moving toes associated with acute axonal sensory polyneuropathy. Basal Ganglia. 2016;6(4):195-6.
Jokela ME, Joutsa J, Udd B. Evolving neuromuscular phenotype in a patient with a heterozygous CHCHD10 p.G66V mutation. J Neurol. 2016;263(7):1461-1.
Johansson JJ, Alakurtti K, Joutsa J, Tohka J, Ruotsalainen U, Rinne JO. Comparison of manual and automatic techniques for substriatal segmentation in 11C-raclopride high-resolution PET studies. Nucl Med Commun. 2016;37(10):1074-87.
Mäkinen E, Joutsa J, Isotalo J, Kaasinen V. No relevant midbrain atrophy in Parkinson’s disease. Acta Neurol Scand. 2016;134(5):378-81.
Hirvioja J#, Joutsa J#, Wahlsten P, Korpela J. Recurrent paraparesis and death of a patient with ‘whippet’ abuse. Oxf Med Case Reports. 2016;2016(3):41-3. #Equal contribution
Jaakkola E, Joutsa J, Kaasinen V. Predictors of normal and abnormal outcome in clinical brain dopamine transporter imaging. J Neural Transm (Vienna). 2016;123(3):205-9.
2015
Sillanpää M, Anttinen A, Rinne JO, Joutsa J, Hermann B, Sonninen P, Erkinjuntti M, Karrasch M, Tiitta P, Shinnar S. Childhood-onset epilepsy five decades later. A prospective population-based cohort study. Epilepsia. 2015;131(19):1811-5.
Korpela J, Joutsa J, Rinne JO, Bergman J, Kaasinen V. Hypermetabolism of olivary nuclei in a patient with progressive ataxia and palatal tremor. Tremor Other Hyperkinet Mov (N Y). 2015;5:342.
Kemppainen NM, Joutsa J, Johansson J, Scheinin NM, Någren K, Rokka J, Parkkola R, Rinne JO. Long-term interrelationship between brain metabolism and amyloid deposition in mild cognitive impairment. J Alzheimer Dis. 2015;48(1):123-33
Joutsa J, Johansson J, Noponen T, Seppänen M, Kaasinen V. Dorsal-to-ventral shift in midbrain dopaminergic projections and increased thalamic/raphe serotonergic function in early Parkinson’s disease. J Nucl Med. 2015;56(7):1036-41
Alakurtti K, Johansson J, Joutsa J, Laine M, Bäckman L, Nyberg L, Rinne JO. Long-term test-retest reliability of striatal and extrastriatal dopamine D2/3 receptor binding: study with [(11)C]raclopride and high-resolution PET. J Cerebr Blood Flow Metab 2015;35(7):1199-205
Joutsa J, Johansson J, Kaasinen V. Is occipital cortex a valid reference region in [123I]FP-CIT SPECT imaging? Clin Nucl Med 2015;40(7):615-6
Kaasinen V, Joutsa J, Noponen T, Johansson J, Seppänen M. Effects of aging and gender on striatal and extrastriatal [123]FP-CIT binding in Parkinson’s disease. Neurobiol Aging. 2015;36(4):1757-63.
Varrone A, Oikonen V, Forsberg A, Joutsa J, Takano A, Solin O, Haaparanta-Solin M, Nag S, Nakao R, Al Tawil N, Wells LA, Rabiner EA, Valencia R, Schultze-Mosgau M, Thiele A, Vollmer S, Dyrks T, Lehman L, Heinrich T, Hoffman A, Norberg A, Halldin C, Rinne JO. Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects. Eur J Nucl Med Mol Imaging. 2015;42(3):438-46.
Joutsa J#, Voon V#, Johansson J, Niemelä S, Bergman J, Kaasinen V. Brain dopamine function and inter-temporal choice. Transl Psychiatry 2015;5:e491. Corrigendum in 2015;5e520. #Equal contribution
Joutsa J, Suomela M, Jutila L, Erkinjuntti M, Soilu-Hänninen M, Müller M. Vagusstimulaattorin aiheuttama unenaikainen hengityshäiriö [Respiratory disturbance during sleep induced by vagus nerve stimulator]. Duodecim. 2015;131(19):1811-5.
2014
Kaasinen V, Joutsa J, Noponen T, Päivärinta M. Akinetic crisis in Parkinson’s disease is associated with a severe loss of striatal dopamine function: a report of two cases. Case Rep Neurol. 2014;6(3):275-280.
Jaakkola E, Kaasinen V, Siri C, Martikainen K, Cilia R, Niemelä S, Joutsa J. Impulse control disorders are associated with multiple psychiatric symptoms in Parkinson’s disease. J Parkinsons Dis. 2014;4(3):507-15.
Joutsa J, Gardberg M, Röyttä M, Kaasinen V. Diagnostic accuracy of parkinsonism syndromes by general neurologists. Parkinsonism Relat Disord. 2014;20(8):840-4.
Kaasinen V, Kinos M, Joutsa J, Seppänen M, Noponen T. Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s disease. Eur J Nucl Med Mol Imaging 2014;41(10):1931-7.
Joutsa J, Hirvonen MM, Arponen E, Hietala J, Kaasinen V. DRD2-related TaqIA genotype is associated with dopamine release during a gambling task. J Addict Med. 2014;8(4):294-5. (Letter)
Ellfolk U, Joutsa J, Rinne JO, Parkkola R, Karrasch M. Striatal volume is related to phonemic verbal fluency but not to semantic or alternating verbal fluency in early Parkinson’s disease. J Neural Trasm. 2014;121(1):33-40.
2013
Ellfolk U, Joutsa J, Rinne JO, Parkkola R, Jokinen P, Karrasch M. Brain volumetric correlates of memory in early Parkinson's disease. J Parkinsons Dis. 2013;3(4):593-601.
Joutsa J, Rinne JO, Eskola O, Kaasinen V. Reduced striatal dopamine synthesis capacity is associated with symptoms of depression in patients with de novo unmedicated Parkinson’s disease. J Parkinsons Dis. 2013;3(3):325-9.
Posti J, Joutsa J, Karhu J, Kotilainen E. Etenevän parapareesin harvinaisia syitä [Rare causes of progressive paraparesis]. Duodecim 2013;129(24):2647-53.
Joutsa J, Kaasinen V. Parkinsonin taudin impulssikontrollihäiriöt [Impulse control disorders in Parkinson’s disease].Duodecim 2013;129(22):2351-8.
2012
Joutsa J, Martikainen K, Vahlberg T, Kaasinen V. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord. 2012;18(10):1079-83.
Kaasinen V, Jokinen P, Joutsa J, Eskola O, Rinne JO. Seasonality of striatal dopamine synthesis capacity in Parkinson’s disease. Neusci Lett. 2012;530(1):80-4.
Ellfolk U, Huurinainen S, Joutsa J, Karrasch M. The effect of encoding condition on free recall in Parkinson’s disease: Incidental and intentional memory are equally affected. Clin Neuropsychol. 2012;26:909-25.
Joutsa J, Martikainen K, Kaasinen V. Parallel appearance of compulsive behaviors and artistic creativity in Parkinson’s disease. Case Rep Neurol. 2012;4:77-83.
Joutsa J, Martikainen K, Niemelä S, Johansson J, Forsback S, Rinne JO, Kaasinen V. Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders. Mov Disord. 2012;27:778-82.
Bhidayasiri R, Chotipanich C, Joutsa J, Tepmongkol S, Wannaschai N, Johansson J, Juiklom W, Rinne JO. Boxing and Parkinson disease: a link or a myth? An 18F-FDOPA PET/CT study in retired Thai traditional boxers. Parkinsonism Relat Disord. 2012;18:694-6.
Joutsa J, Johansson J, Niemelä S, Ollikainen A, Hirvonen MM, Piepponen P, Voon V, Arponen E, Alho H, Rinne JO, Hietala J, Kaasinen V. Mesolimbic dopamine release during gambling is linked to symptom severity in pathological gambling. NeuroImage. 2012;60(4):1992-9.
Joutsa J, Martikainen K, Vahlberg T, Voon V, Kaasinen V. Impulse control disorders and depression in Finnish patients with Parkinson’s disease. Parkinsonism Relat Disord. 2012;18:155-60.
Kwon MS, Vorobyev S, Kännälä S, Toivonen T, Johansson J, Teräs M, Joutsa J, Tuominen L, Rinne JO, Laine M, Hämäläinen H. No effects of short-term GSM mobile radiation on cerebral blood flow as measured by positron emission tomography. Bioelectromagnetics. 2012 33(3):247-56.
2011
Joutsa J, Saunavaara J, Parkkola R, Niemelä S, Kaasinen V. Extensive abnormality of brain white matter integrity in pathological gambling. Psychiatry Res. 2011;194(3):340-6.
2010
Stokes A#, Joutsa J#, Ala-Aho R, Pitchers M, Pennington CJ, Martin C, Premachandra DJ, Okada Y, Peltonen J, Grenman R, James HA, Edwards DR, Kähäri VM. Expression profiles and clinical correlations of degradome components in the tumor microenvironment of head and neck squamous cell carcinoma. Clin Cancer Res. 2010;16(7):2022-35. #Equal contribution
